List of Studies ( Metabolite:Enterolactone)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST002026 | AN003296 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/GC) | Feces | Human | UC Davis | normalized peak height | |
ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | osmolality normalized scaled imputed | |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | peak area | |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | peak area | |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | peak area | |
ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University School of Medicine | Peak area | |
ST001122 | AN001847 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part II) | Urine | Human | Interstitial cystitis | University of California, Davis | Peak height |
ST002090 | AN003414 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) | Feces | Mouse | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed |